❌

Reading view

Europe’s moment to lead: Backing research in a global race

Europe’s population is aging, with an increased burden of chronic diseases: more than half of adults in the European Union are now overweight and one in six is obese.1 In parallel, we are exposed to new threats from biosecurity, the malicious use of artificial intelligence, climate-related health threats and drug-resistant superbugs.

We are not passive bystanders. European teachers, biologists, nurses and manufacturers have all played a role in developing innovations that protect our populations and help them thrive. Now is not the time to step back. We believe health research and innovation are economic drivers of Europe’s future, not discretionary costs. Backing research in health as a pillar of our future in a global race is the right choice. It enables Europe to lead and support sustainable growth, as a pillar of the new architecture of global health.

We believe health research and innovation are economic drivers of Europe’s future, not discretionary costs.

The evidence is all around us. A vaccine developed against tuberculosis has been a frontline bladder cancer treatment for over 40 years,2 technology first developed for a malaria vaccine now helps protect millions against shingles,3 and mRNA research, developed over decades, enabled Europe’s fastest-ever vaccine response to Covid-19.4 Scientific progress rarely remains confined to the place or problem where it begins.

Public budgets are under pressure, but these achievements show what investment in global health research can deliver. Pressure can be a catalyst, focusing minds, sharpening priorities and turning constraints into innovative breakthroughs. Too often, the debate is framed in terms of what Europe gives. Too rarely is it framed in terms of what Europe and its people receive in return. With commitment, we can find pragmatic ways to maximize our investments as a union.

Building on its strengths in life sciences, Europe can advance its health sovereignty and seize the emerging opportunities in scientific discovery, next-generation vaccines and biomanufacturing. Basic and applied research become new technologies, intellectual property, skilled jobs and revenues that protect European health, growth and wealth. Together, these returns are Europe’s Health Dividend.

Europe’s health, security and prosperity depend on its ability to contribute to, and benefit from, global networks of research and innovation. Retreating from global research would not reduce vulnerability; it would increase it. Investing and engaging beyond our borders is a strategic imperative for Europe.

Retreating from global research would not reduce vulnerability; it would increase it. Investing and engaging beyond our borders is a strategic imperative for Europe.

At a time when public investment must deliver its value, we can find ways to maximize the impact of European money by working and funding a shared agenda together, not as disjointed nations. Health research remains one of the clearest examples of an investment that strengthens Europe’s future while delivering benefits today.

Back Europe’s Health Dividend. Sign the declaration.

SIGNATORIES

Europe’s Health Dividend is funded by the Gates Foundation and Coefficient Giving.


References

  1. Eurostat. Over half of adults in the EU are overweight. 4 September 2026. https://ec.europa.eu/eurostat/web/products-eurostat-news/w/ddn-20260904-1
  2. Kluemper A, Morris K, Mellon MJ. From plague to the promise: The journey of Bacille Calmette–Guérin. Bladder. 2024;11(4):e21200022. https://doi.org/10.14440/bladder.2024.0035
  3. Impact Global Health. From malaria research to protecting aging populations: AS01 Adjuvant in Shingrix. https://www.impactglobalhealth.org/insights/report-library/shingrix-vaccine
  4. European Medicines Agency. EMA recommends first COVID-19 vaccine for authorisation in the EU. 21 December 2020. https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu

Disclaimer

POLITICAL ADVERTISEMENT

  • The sponsor is Europe’s Health Dividend.
  • The advertisement is linked to investment in global health research and development and its contribution to Europe’s health, security, resilience and economic competitiveness.

More information here.

  •  

Microsoft outage renews European calls to detox from US tech

DUBLIN — Friday’s widespread outage of Microsoft products has sparked a new wave of calls for Europe to control its own digital infrastructure — especially with the uncertain future of artificial intelligence at stake.

“Only 20% of European digital services run on European infrastructure,” Mistral CEO Arthur Mensch said in remarks Friday after he addressed EU national leaders during their first-ever meeting on artificial intelligence in Dublin.

The money spent on foreign, U.S. or Chinese, technology “could be reinvested here, on infrastructure we control and [to] finance European research and development,” said the boss of Europe’s leading AI frontier lab.

Mensch didn’t specifically address the Microsoft outage, which lasted nearly 24 hours and affected millions of users in 74 countries. Still, the shutdown of key tools like Outlook email and Teams messaging impacted plenty of the tech and government leaders gathered in Dublin to chart Europe’s AI future.

French President Emmanuel Macron closed the day with a post on X: “Our independence cannot be outsourced. It must be built here at home, in Europe,” he wrote. “When it comes to artificial intelligence, too, Europe has everything it takes to compete. We have no time to lose.”

An EU diplomat present at the leaders’ talks said that “we need to pick up speed, permitting and investment to compete on the world market, to have sovereignty.”

Tech sovereignty, including control over the cloud, chips and models that power AI, has been a rallying cry of the second mandate of European Commission President Ursula von der Leyen, and was one of the key agenda items at Friday’s gathering of the leaders of the EU’s 27 member countries.

“We have outsourced too much of our digital infrastructure to actors outside the EU,” Finnish European Parliament lawmaker Aura Salla said in a press release Friday following the outage. She suggested that government contracts specifically “must support European technology.”

Others zoned in on the risk created by relying on digital infrastructure controlled by a couple of large companies.

The Microsoft outage is a “reminder of the systemic risk created by concentrating digital infrastructure with a few global tech giants,” said Sebastian Toffaletti, secretary general of the Digital SME Alliance, in a statement shared with POLITICO.

In the U.K., the Liberal Democrat party’s tech spokesperson Victoria Collins said the outage demonstrated the need for a digital sovereign strategy, saying: “We need urgent action to stop relying on a handful of companies.”

In Germany, lawmaker Johannes Schätzl from the Social Democratic Party said it raised questions about public procurement. “Digital sovereignty must be measured by whether we can remain operational even during outages like this,” he said.

Joe Bambridge and Kilian Hocke contributed reporting.

  •  
❌